(Q37786162)

23 August 2017

title

The dilemma of multidrug-resistant gram-negative bacteria (English)

1 reference

23 August 2017

The Dilemma of Multidrug-Resistant Gram-Negative Bacteria (English)

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

8 July 2024

main subject

Gram-negative bacteria

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20823700

8 July 2024

author name string

Lee S. Engel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20823700

8 July 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0002962915315032?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

https://api.elsevier.com/content/article/PII:S0002962915315032?httpAccept=text/plain

8 July 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

American Journal of the Medical Sciences

8 July 2024

published in

1 reference

23 August 2017

volume

340

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

232-237

1 reference

Estimating health care-associated infections and deaths in U.S. hospitals, 2002

23 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

8 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Gram-negative antibiotic resistance: there is a price to pay.

8 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria

8 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

8 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients

8 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

8 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

8 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature

8 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa

8 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

8 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

8 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.

8 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Overview of nosocomial infections caused by gram-negative bacilli

8 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Major factors affecting the emergence and re-emergence of infectious diseases.

8 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century

8 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data

8 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

The clinical consequences of antimicrobial resistance

8 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children

8 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces

8 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospita

8 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Predictive model of antimicrobial-resistant Gram-negative bacteremia at the ED

8 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

8 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Evaluation and management of geriatric infections in the emergency department

8 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

8 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Prevalence and risk factors for multidrug resistant uropathogens in ED patients.

8 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Epidemiology and impact of imipenem resistance in Acinetobacter baumannii

8 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit

8 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

8 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Cost of Gram-negative resistance

8 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay

8 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum

8 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

8 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients

8 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

8 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

8 July 2024

41

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation

8 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Antibiotics for emerging pathogens

8 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited

8 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Colistin and polymyxin B in critical care.

8 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats

8 July 2024

46

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin

8 July 2024

47

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer

8 July 2024

48

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients

8 July 2024

49

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram

8 July 2024

50

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Rifampicin combined regimens for gram-negative infections: data from the literature.

8 July 2024

51

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Antibiotics in the intensive care unit: focus on agents for resistant pathogens

8 July 2024

52

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

New antibiotic agents for bloodstream infections

8 July 2024

53

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution

8 July 2024

54

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

8 July 2024

55

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Multidrug-resistant Gram-negative infections: what are the treatment options?

8 July 2024

56

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Colistin in the 21st century

8 July 2024

57

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

8 July 2024

58

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181E939C3

8 July 2024

Identifiers

1 reference

23 August 2017

1 reference